MGIA
ALXO icon

Moneta Group Investment Advisors’s ALX Oncology ALXO Stock Holding History

Moneta Group Investment Advisors’s Portfolio ALXO Stock Details ALXO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$30.5K Hold
15,196
– – ﹤0.01% 801
2025
Q4 		$17.2K Hold
15,196
– – ﹤0.01% 805
2025
Q3 		$27.8K Hold
15,196
– – ﹤0.01% 784
2025
Q2 		$6.31K Hold
15,196
– – ﹤0.01% 706
2025
Q1 		$9.47K Hold
15,196
– – ﹤0.01% 666
2024
Q4 		$25.4K Buy
+15,196
New +$23.4K ﹤0.01% 658

Other funds holding ALXO

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
AC
Almitas Capital Santa Monica, California $443M AUM 42.36% 1-Year Est. Return

Moneta Group Investment Advisors's ALXO Position: Q1 2026 in Review

Moneta Group Investment Advisors held its ALX Oncology (ALXO) position steady in Q1 2026 at 15,196 shares worth $30.5K. The position accounts for ﹤0.01% of the portfolio, ranked #801.

Moneta Group Investment Advisors first reported a position in ALXO in Q4 2024 and has held it in 6 quarters since. 69 funds tracked by Wall St. Rank hold ALXO as of Q1 2026.

  • Moneta Group Investment Advisors held 15,196 shares of ALX Oncology worth $30.5K as of Q1 2026.
  • Moneta Group Investment Advisors left its ALX Oncology share count unchanged in Q1 2026.
  • ALX Oncology made up ﹤0.01% of Moneta Group Investment Advisors's portfolio in Q1 2026, its #801 holding.
  • Moneta Group Investment Advisors first reported a position in ALX Oncology in Q4 2024 and has held it in 6 quarters since.
  • 69 funds tracked by Wall St. Rank held ALX Oncology as of Q1 2026.

Based on Moneta Group Investment Advisors's 13F filing for Q1 2026, filed 12 May 2026.